Community Fundraising October Wrap-Up
4 November 2019
As we say goodbye to October, it is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma with each event they organise.
Brothers Jack and Sam Glasson wanted to shave their heads in early October to show their appreciation and respect for all melanoma patients. They raised $1500 for MIA – thank you, boys!
Over two nights, Creative for a Cause presented 'Warped', a musical variety show where all proceeds were donated to MIA in loving memory of Diana Perini. The production was a huge success, raising over $10,000! Thank you to everyone who participated and special thanks to Greta Georgiou.
Amelia and Michael Wood have been hosting the Michael Wood Electrical Golf Day for 12 years with many different charity beneficiaries. This year, after the loss of close family friend Janelle to melanoma, they decided to fundraise for MIA. Over $3000 was raised on the day by their 81 players and spectators. About 20 members of Janelle's family made the trip to the town of Jandowae for 'A Day for J', with Janelle's son and 7-year-old grandson driving 800kms to be there! Thank you to all involved.
Matthew Limbrey and Liz Gray both competed in the Bowral Classic, a 120km bicycle race to raise money for MIA, raising almost $1000 between them! Liz also contributed to her fundraiser through the sale of her handcrafted greeting cards.
Adrian Gilchrist has shaved his head each year since 2013 after he lost his father, David, in 2011 to melanoma. This year, he raised $1000 for MIA. Thank you to everyone who donated to 'Bald Gilly'!
Malcolm Price and Elizabeth Liu from Poolwerx Turramurra have both been touched by melanoma in different ways. The team at Poolwerx Turramurra dedicated the last weekend in October to raise funds for MIA through the Poolwerx Turramurra Charity BBQ. They raised $1185 with additional funds still to come from Poolwerx itself. Thank you to everyone involved!
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.